156 related articles for article (PubMed ID: 35152975)
21. Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement.
; Curry SJ; Krist AH; Owens DK; Barry MJ; Caughey AB; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2018 Jul; 320(2):177-183. PubMed ID: 29998344
[TBL] [Abstract][Full Text] [Related]
22. Association between plasma monocyte chemoattractant protein-1 levels and the extent of atherosclerotic peripheral artery disease.
Satiroglu O; Uydu HA; Demir A; Bostan M; Atak M; Bozkurt E
Tohoku J Exp Med; 2011 Aug; 224(4):301-6. PubMed ID: 21799302
[TBL] [Abstract][Full Text] [Related]
23. Novel screening metric for the identification of at-risk peripheral artery disease patients using administrative claims data.
Bali V; Yermilov I; Coutts K; Legorreta AP
Vasc Med; 2016 Feb; 21(1):33-40. PubMed ID: 26608733
[TBL] [Abstract][Full Text] [Related]
24. PAD in women: the ischemic continuum.
Pollak AW
Curr Atheroscler Rep; 2015 Jun; 17(6):513. PubMed ID: 25939674
[TBL] [Abstract][Full Text] [Related]
25. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
[TBL] [Abstract][Full Text] [Related]
26. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50).
Bonaca MP; Gutierrez JA; Creager MA; Scirica BM; Olin J; Murphy SA; Braunwald E; Morrow DA
Circulation; 2016 Mar; 133(10):997-1005. PubMed ID: 26826179
[TBL] [Abstract][Full Text] [Related]
27. [Ankle-brachial index screening for peripheral artery disease in high cardiovascular risk patients. Prospective observational study of 370 asymptomatic patients at high cardiovascular risk].
Rada C; Oummou S; Merzouk F; Amarir B; Boussabnia G; Bougrini H; Benzaroual D; Elkarimi S; Elhattaoui M
J Mal Vasc; 2016 Dec; 41(6):353-357. PubMed ID: 27865565
[TBL] [Abstract][Full Text] [Related]
28. Asymptomatic peripheral artery disease: Silent but deadly.
Behroozian AA; Beckman JA
Prog Cardiovasc Dis; 2021; 65():2-8. PubMed ID: 33617896
[TBL] [Abstract][Full Text] [Related]
29. Medical management of patients with peripheral arterial disease.
Poredoš P; Jezovnik M; Kalodiki E; Andreozzi G; Antignani PL; Clement D; Comerota A; Fareed J; Fletcher J; Fras Z; Griffin M; Markel A; Martini R; Mignano A; Nicolaides A; Novo G; Novo S; Roztočil K; Visona A
Int Angiol; 2015 Feb; 34(1):75-93. PubMed ID: 24916346
[TBL] [Abstract][Full Text] [Related]
30. Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction.
Hirsch AT; Gotto AM
Vasc Med; 2002; 7(4):323-31. PubMed ID: 12710848
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Studies for the Evaluation of Peripheral Artery Disease.
Banchs Viña H; Claudio H; Mesa M; López-Candales A
Bol Asoc Med P R; 2015; 107(3):42-5. PubMed ID: 26742195
[TBL] [Abstract][Full Text] [Related]
32. Screening for Peripheral Artery Disease Using the Ankle-Brachial Index: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Guirguis-Blake JM; Evans CV; Redmond N; Lin JS
JAMA; 2018 Jul; 320(2):184-196. PubMed ID: 29998343
[TBL] [Abstract][Full Text] [Related]
33. YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients.
Höbaus C; Tscharre M; Herz CT; Pesau G; Wrba T; Koppensteiner R; Schernthaner GH
Atherosclerosis; 2018 Jul; 274():152-156. PubMed ID: 29783062
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of peripheral arterial disease.
Diehm C; Kareem S; Lawall H
Vasa; 2004 Nov; 33(4):183-9. PubMed ID: 15623192
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular morbidity and mortality in peripheral arterial disease.
Eberhardt RT; Coffman JD
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):209-17. PubMed ID: 15379611
[TBL] [Abstract][Full Text] [Related]
36. Peripheral arterial disease (PAD) - A challenging manifestation of atherosclerosis.
Nordanstig J; Behrendt CA; Bradbury AW; de Borst GJ; Fowkes F; Golledge J; Gottsater A; Hinchliffe RJ; Nikol S; Norgren L
Prev Med; 2023 Jun; 171():107489. PubMed ID: 37031910
[TBL] [Abstract][Full Text] [Related]
37. [Peripheral artery disease as supplemental diagnosis in coronary heart disease--influence on diagnostics, treatment and prognosis].
Espinola-Klein C; Savvidis S; Kopp H
Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S40-2. PubMed ID: 24446044
[TBL] [Abstract][Full Text] [Related]
38. Premature atherosclerotic peripheral artery disease: An underrecognized and undertreated disorder with a rising global prevalence.
Mehta A; Dhindsa DS; Hooda A; Nayak A; Massad CS; Rao B; Makue LF; Rajani RR; Alabi O; Quyyumi AA; Escobar GA; Wells BJ; Sperling LS
Trends Cardiovasc Med; 2021 Aug; 31(6):351-358. PubMed ID: 32565142
[TBL] [Abstract][Full Text] [Related]
39. The 100 most cited articles in the diagnosis and management of peripheral artery disease.
Choinski K; Koleilat I; Phair J
J Vasc Surg; 2021 Jul; 74(1):135-152.e4. PubMed ID: 33592290
[TBL] [Abstract][Full Text] [Related]
40. [Lower limb arterial disease and renal artery stenosis].
Guijarro C; Mostaza JM; Hernández-Mijares A
Clin Investig Arterioscler; 2013; 25(5):218-23. PubMed ID: 24238748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
